Omega Healthcare Investors (BSP:O2HI34) PE Ratio without NRI: 7.34 (As of Jun. 25, 2026) — 70% Below Median


BSP:O2HI34 Omega Healthcare Investors Inc BSP:O2HI34
49 GF Score
Price R$77.02
GF Value R$62.11
Valuation Modestly Overvalued
! 6 Warning Signs
View Full Analysis

What is Omega Healthcare Investors PE Ratio without NRI?

Omega Healthcare Investors BSP:O2HI34 -0.03% 49 PE Ratio without NRI is 7.34 as of Jun. 25, 2026, which is 70% below its 10-year median of 24.80. GuruFocus rates BSP:O2HI34 with a GF Score™ of 49/100 and a GF Value™ of R$62.11 (Modestly Overvalued). The stock has 6 warning signs investors should review. Among 752 REITs companies, Omega Healthcare Investors ranks worse than 75.27% on this metric.

The PE Ratio without NRI, or P/E Ratio without non-recurring items, is a financial ratio used to compare a company's market price to its EPS without NRI. As of today (2026-06-25), Omega Healthcare Investors's share price is R$77.02. Omega Healthcare Investors's EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2026 was R$10.50. Therefore, Omega Healthcare Investors's PE Ratio without NRI for today is 7.34.

During the past 13 years, Omega Healthcare Investors's highest PE Ratio without NRI was 66.82. The lowest was 14.10. And the median was 24.80.

Omega Healthcare Investors's EPS without NRI for the three months ended in Mar. 2026 was R$2.43. Its EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2026 was R$10.50.

As of today (2026-06-25), Omega Healthcare Investors's share price is R$77.02. Omega Healthcare Investors's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was R$11.17. Therefore, Omega Healthcare Investors's PE Ratio (TTM) for today is 6.89.

Good Sign:

Omega Healthcare Investors Inc stock PE Ratio (=22.89) is close to 3-year low of 21.48.

During the past years, Omega Healthcare Investors's highest PE Ratio (TTM) was 81.72. The lowest was 13.63. And the median was 25.19.

Omega Healthcare Investors's EPS (Diluted) for the three months ended in Mar. 2026 was R$2.46. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was R$11.17.

Omega Healthcare Investors's EPS (Basic) for the three months ended in Mar. 2026 was R$2.46. Its EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2026 was R$11.23.


Omega Healthcare Investors  (BSP:O2HI34) PE Ratio without NRI Explanation

The PE Ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. For example, if a company earns $2 a share per year, and the stock is traded at $30, the PE Ratio is 15. Therefore it takes 15 years for the company to earn back the $30 you paid for its stock, assuming the earnings stays constant over the next 15 years.

In real business, earnings never stay constant. If a company can grow its earnings, it takes fewer years for the company to earn back the price you pay for the stock. If a company's earnings decline it takes more years. As a shareholder, you want the company to earn back the price you pay as soon as possible. Therefore, lower P/E stocks are more attractive than higher P/E stocks so long as the PE Ratio is positive. Also for stocks with the same PE Ratio, the one with faster growth business is more attractive.

If a company loses money, the PE Ratio becomes meaningless.

To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the PE Ratio divided by the growth ratio. He thinks a company with a PE Ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a PE Ratio of 20, instead of a company growing 10% a year with a PE Ratio of 10.

Because the PE Ratio measures how long it takes to earn back the price you pay, the PE Ratio can be applied to the stocks across different industries. That is why it is the one of the most important and widely used indicators for the valuation of stocks.

Similar to the PE Ratio or PS Ratio or Price-to-Operating-Cash-Flow or Price-to-Free-Cash-Flow , the PE Ratio without NRI measures the valuation based on the earning power of the company. This is where it is different from the PB Ratio , which measures the valuation based on the company's balance sheet.


Be Aware

Investors need to be aware that the PE Ratio can be misleading a lot of times, especially when the underlying business is cyclical and unpredictable. As Peter Lynch pointed out, cyclical businesses have higher profit margins at the peaks of the business cycles. Their earnings are high and PE Ratio s are artificially low. It is usually a bad idea to buy a cyclical business when the PE Ratio is low. A better ratio to identify the time to buy a cyclical businesses is the PS Ratio.


Omega Healthcare Investors PE Ratio without NRI Related Terms


Omega Healthcare Investors PE Ratio without NRI Historical Data

* Premium members only.

The historical data trend for Omega Healthcare Investors's PE Ratio without NRI can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Omega Healthcare Investors PE Ratio without NRI Chart

Omega Healthcare Investors Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
PE Ratio without NRI
Get a 7-Day Free Trial Premium Member Only Premium Member Only 21.06 41.78 28.63 23.12 24.72

Omega Healthcare Investors Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
PE Ratio without NRI Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 23.18 22.32 25.22 24.72 22.53

BSP:O2HI34 vs DOC, AHR, CTRE: PE Ratio without NRI Comparison

For the REIT - Healthcare Facilities subindustry, Omega Healthcare Investors's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Omega Healthcare Investors PE Ratio without NRI vs REITs Industry

For the REITs industry and Real Estate sector, Omega Healthcare Investors's PE Ratio without NRI distribution charts can be found below:

* The bar in red indicates where Omega Healthcare Investors's PE Ratio without NRI falls into.


BSP:O2HI34
49GF Score
Omega Healthcare Investors Inc BSP:O2HI34
PE Ratio without NRI is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Omega Healthcare Investors PE Ratio without NRI Calculation

The PE Ratio without NRI, or P/E Ratio without non-recurring items, is a financial ratio used to compare a company's market price to its EPS without NRI. Regular PE Ratio can be affected by Non Operating Income such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than regular PE Ratio.

Omega Healthcare Investors's PE Ratio without NRI for today is calculated as

PE Ratio without NRI=Share Price/ EPS without NRI
=77.02/10.496
=7.34

Omega Healthcare Investors's Share Price of today is R$77.02.
Omega Healthcare Investors's EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was R$10.50.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

There are at least three kinds of PE Ratios used by different investors. They are Trailing Twelve Month PE Ratio, Forward PE Ratio, or PE Ratio without NRI. A new PE Ratio based on inflation-adjusted normalized PE Ratio is called Shiller PE Ratio, after Yale professor Robert Shiller.

In the case of PE Ratio without NRI, the reported earnings less the non-recurring items are used.

In the calculation of PE Ratio (TTM), the earnings per share used are the earnings per share over the past 12 months.

For Forward PE Ratio, the earnings are the expected earnings for the next twelve months.

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. Since it looks at the average over the last 10 years, Shiller PE Ratio is also called PE10.

Frequently Asked Questions Learn more about PE Ratio without NRI →
What does a PE Ratio without NRI of 7.34 mean?
Omega Healthcare Investors (BSP:O2HI34) has a PE Ratio without NRI of 7.34 as of Jun. 25, 2026. P/E without nonrecurring items is the ratio of share price to a company's earnings less one-time charges. View historical data on Omega Healthcare Investors and its competitors. This is 70% below median its historical median of 24.80. Over the past decade, Omega Healthcare Investors' PE Ratio without NRI has ranged from 14.10 to 66.82. According to the industry distribution chart, Omega Healthcare Investors ranks #566 out of 752 companies in the REITs industry, placing it in the top 75.3%.
Is Omega Healthcare Investors' PE Ratio without NRI too high?
Omega Healthcare Investors' current PE Ratio without NRI of 7.34 is 70% below median its 10-year median of 24.80. Over the past 10 years, this metric has ranged from a low of 14.10 to a high of 66.82. The REITs industry median PE Ratio without NRI is 13.92. Omega Healthcare Investors' value of 7.34 is 47.3% below this industry median. Based on the distribution chart, Omega Healthcare Investors ranks #566 out of 752 companies in the REITs industry, which is in the bottom quartile relative to peers. Overall, Omega Healthcare Investors has a GF Score™ of 49/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Omega Healthcare Investors' PE Ratio without NRI compare to DOC and AHR?
According to the REITs industry distribution chart, Omega Healthcare Investors ranks #566 out of 752 companies for PE Ratio without NRI. This places Omega Healthcare Investors in the lower half of its industry. The industry median PE Ratio without NRI is 13.92. Omega Healthcare Investors' value of 7.34 is 47.3% below this benchmark. Historically, Omega Healthcare Investors' own PE Ratio without NRI has ranged from 14.10 to 66.82 over the past decade. While the company's 10-year median is 24.80 vs. the industry median of 13.92, Omega Healthcare Investors has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PE Ratio without NRI for a REITs company?
The median PE Ratio without NRI among REITs companies is 13.92, based on 752 companies in the industry. Companies in the top quartile (top 25%) have a PE Ratio without NRI significantly above this median, while those in the bottom quartile fall well below. However, PE Ratio without NRI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Omega Healthcare Investors's current PE Ratio without NRI of 7.34 is 47.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PE Ratio without NRI mean?
A high PE Ratio without NRI can signal that a stock is expensive relative to its fundamentals. P/E without nonrecurring items is the ratio of share price to a company's earnings less one-time charges. View historical data on Omega Healthcare Investors and its competitors. For the REITs industry, the median PE Ratio without NRI is 13.92 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Omega Healthcare Investors's current PE Ratio without NRI is 7.34, which is 70% below median its own 10-year median of 24.80. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Omega Healthcare Investors stock overvalued right now?
Based on GuruFocus' analysis, Omega Healthcare Investors (BSP:O2HI34) is currently considered Modestly Overvalued. The stock's GF Value™ is R$62.11, compared to a current price of R$77.02 — trading 24% above its estimated fair value. The current PE Ratio without NRI is 7.34, which is 70% below median its 10-year median of 24.80 and 47.3% below the REITs industry median of 13.92. Omega Healthcare Investors' overall GF Score™ is 49/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PE Ratio without NRI calculated?
PE Ratio without NRI is calculated from a company's financial statements. For Omega Healthcare Investors (BSP:O2HI34), the current PE Ratio without NRI is 7.34 as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Omega Healthcare Investors (BSP:O2HI34) Overvalued in 2026?

Based on GuruFocus' analysis, Omega Healthcare Investors stock appears to be overvalued. The current stock price of R$77.02 is trading 24% above its estimated GF Value™ of R$62.11. GuruFocus considers Omega Healthcare Investors to be Modestly Overvalued.

Key valuation signals for BSP:O2HI34:

  • PE Ratio without NRI: 7.34 (70% below median its 10-year median of 24.80)
  • GF Value™: R$62.11 vs. price of R$77.02 (24% above fair value)
  • GF Score™: 49/100 with 6 warning signs
  • Industry Position: 47.3% below the REITs median (#566 of 752)

No single metric tells the full story. See the BSP:O2HI34 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Omega Healthcare Investors Business Description

Industry Real EstateREITs
Address 303 International Circle, Suite 200, Hunt Valley, MD, USA, 21030
Omega Healthcare Investors Inc is a real estate investment trust that invests in healthcare-related real estate properties located in the United States (U.S.), the United Kingdom (U.K.), and Canada. The company's objective is to provide attractive returns to investors while serving as the preferred capital partner to its third-party healthcare operating companies and affiliates, as well as other third-party healthcare operators, allowing them to focus on delivering a high level of care to their resident patients. Omega's investment portfolio mainly consists of skilled nursing facilities, assisted living facilities (ALFs), including care homes in the U.K., independent living facilities, rehabilitation and acute care facilities, and continuing care retirement communities.
49GF Score

Get the complete analysis for BSP:O2HI34

PE Ratio without NRI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

R$77.02
Price
R$62.11
GF Value